Tag: St Jude Medical

St Jude Medical announces Merlin cybersecurity updates

St Jude Medical has announced that it will immediately deploy the latest release of cyber security updates for its Merlin remote monitoring system, used...
DAPT

Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...

ADVERTORIAL: Enhanced deliverability means Trifecta™ valve is now easier to implant

The new St. Jude Medical™ Trifecta™ valve with Glide™ Technology (GT) features several enhancements that make the device easier to implant in patients with...

AHA 2016: MOMENTUM 3 shows HeartMate 3 LVAD improves clinical outcomes...

The results of the MOMENTUM 3 US IDE clinical study, which were presented at a late-breaking clinical trial at the 2016 American Heart Association...

TCT 2016: High implant success rates with St Jude Medical’s Amulet...

A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) indicates...

TCT 2016: FDA approve Amplatzer PFO occluder device ahead of first...

The FDA has approved St Jude Medical’s Amplatzer patent foramen ovale (PFO) occluder device for the prevention of stroke. Announced on 28 October, this...

TCT 2016: ILUMEN III shows some advantages with OCT

ILUMEN III, the first late-breaking to be presented at the 2016 Transcatheter Cardiovascular Therapeutics meeting (29 October-2 November, Washington, DC, USA), has met its...

St Jude Medical shareholders approve merger with Abbott

St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October, St...

TCT 2016: St Jude Medical to highlight latest cardiovascular portfolio

New data for St Jude Medical’s devices and technologies will be presented during late-breaking clinical trial presentations at the 2016 Transcatheter Cardiovascular Therapeutics (TCT)...

St. Jude Medical and Abbott to sell portion of vascular closure...

Abbott and St. Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase price of...

FDA approves St Jude Medical’s PressureWire X guidewire

St Jude Medical has announced the FDA clearance and launch of its PressureWire X guidewire fractional flow reserve (FFR) measurement system. According to a...

St Jude Medical launches trial of Amplatzer Amulet left atrial appendage...

The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will evaluate the safety and effectiveness of the company’s Amplatzer Amulet left...